Study results are based on Surveillance, Epidemiology, and End Results-Medicare data for 166,581 patients receiving surgery or radiation for localized prostate cancer.
Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...
Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
A world-first study shows stabilised hyaluronic acid gel can safely protect the rectum during radiation therapy for ...
An Italian oncologic psychologist warns these patients: “A prostatectomy doesn’t cure anxiety.” Emotional distress can be so ...
Telix Pharmaceuticals meets its FY25 revenue target with strong Q4 growth, expanded U.S. launches and ongoing trials.
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides an update on its commercial and operational ...
Global Radiopharmaceuticals Market Size The global Radiopharmaceuticals market revenue was USD 6761 Million in 2022 and is ...
External beam radiotherapy (EBRT) is a cornerstone of cancer treatment, with ongoing advances in imaging, motion management, ...
A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...
Mohs microscopic surgery and image-guided superficial radiation therapy (IG-SRT) demonstrate high cure rates for non-melanoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results